236 related articles for article (PubMed ID: 19585648)
81. Impact of TRIM5α and TRIM22 Genes Expression on the Clinical Course of Coronavirus Disease 2019.
Tavakoli R; Rahimi P; Hamidi-Fard M; Eybpoosh S; Doroud D; Sadeghi SA; Zaheri Birgani M; Aghasadeghi M; Fateh A
Arch Med Res; 2023 Feb; 54(2):105-112. PubMed ID: 36621405
[TBL] [Abstract][Full Text] [Related]
82. On the relationship between tripartite motif-containing 22 single-nucleotide polymorphisms and COVID-19 infection severity.
Raheem Juhi Al-Kaabi N; Khameneh SC; Montazeri M; Mardasi M; Amroabadi JM; Sakhaee F; Fateh A
Hum Genomics; 2022 Aug; 16(1):33. PubMed ID: 36028902
[TBL] [Abstract][Full Text] [Related]
83. Genome-wide scan in two groups of HIV-infected patients treated with dendritic cell-based immunotherapy.
Moura Rodrigues R; Plana M; Garcia F; Zupin L; Kuhn L; Crovella S
Immunol Res; 2016 Dec; 64(5-6):1207-1215. PubMed ID: 27704462
[TBL] [Abstract][Full Text] [Related]
84. Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease?
Jefferies C; Wynne C; Higgs R
Nat Rev Immunol; 2011 Aug; 11(9):617-25. PubMed ID: 21866173
[TBL] [Abstract][Full Text] [Related]
85. Tripartite Motif 22 and Class II Transactivator Restriction Factors: Unveiling Their Concerted Action against Retroviruses.
Forlani G; Accolla RS
Front Immunol; 2017; 8():1362. PubMed ID: 29093716
[TBL] [Abstract][Full Text] [Related]
86. TRIM62 From Chicken as a Negative Regulator of Reticuloendotheliosis Virus Replication.
Li L; Niu D; Yang J; Bi J; Zhang L; Cheng Z; Wang G
Front Vet Sci; 2020; 7():152. PubMed ID: 32318585
[TBL] [Abstract][Full Text] [Related]
87. The Molecular and Function Characterization of Porcine MID2.
Chen J; Zhou L; Yang Z; Zhao S; Li W; Zhang Y; Xia P
Animals (Basel); 2023 Sep; 13(18):. PubMed ID: 37760252
[TBL] [Abstract][Full Text] [Related]
88. Tripartite motif proteins: an emerging antiviral protein family.
Patil G; Li S
Future Virol; 2019 Feb; 14(2):107-122. PubMed ID: 31406497
[No Abstract] [Full Text] [Related]
89. TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation.
Di Pietro A; Kajaste-Rudnitski A; Oteiza A; Nicora L; Towers GJ; Mechti N; Vicenzi E
J Virol; 2013 Apr; 87(8):4523-33. PubMed ID: 23408607
[TBL] [Abstract][Full Text] [Related]
90. Identification and characterization of multiple TRIM proteins that inhibit hepatitis B virus transcription.
Zhang S; Guo JT; Wu JZ; Yang G
PLoS One; 2013; 8(8):e70001. PubMed ID: 23936368
[TBL] [Abstract][Full Text] [Related]
91. The E3 Ubiquitin Ligase TRIM21 Promotes HBV DNA Polymerase Degradation.
Mu T; Zhao X; Zhu Y; Fan H; Tang H
Viruses; 2020 Mar; 12(3):. PubMed ID: 32245233
[TBL] [Abstract][Full Text] [Related]
92. Nuclear Sensor Interferon-Inducible Protein 16 Inhibits the Function of Hepatitis B Virus Covalently Closed Circular DNA by Integrating Innate Immune Activation and Epigenetic Suppression.
Yang Y; Zhao X; Wang Z; Shu W; Li L; Li Y; Guo Z; Gao B; Xiong S
Hepatology; 2020 Apr; 71(4):1154-1169. PubMed ID: 31402464
[TBL] [Abstract][Full Text] [Related]
93. The interferon-stimulated gene TRIM22: A double-edged sword in HIV-1 infection.
Vicenzi E; Poli G
Cytokine Growth Factor Rev; 2018 Apr; 40():40-47. PubMed ID: 29650252
[TBL] [Abstract][Full Text] [Related]
94. FoxO4 inhibits HBV core promoter activity through ERK-mediated downregulation of HNF4α.
Li L; Li Y; Xiong Z; Shu W; Yang Y; Guo Z; Gao B
Antiviral Res; 2019 Oct; 170():104568. PubMed ID: 31351930
[TBL] [Abstract][Full Text] [Related]
95. Type-I-IFN-Stimulated Gene TRIM5γ Inhibits HBV Replication by Promoting HBx Degradation.
Tan G; Yi Z; Song H; Xu F; Li F; Aliyari R; Zhang H; Du P; Ding Y; Niu J; Wang X; Su L; Qin FX; Cheng G
Cell Rep; 2019 Dec; 29(11):3551-3563.e3. PubMed ID: 31825835
[TBL] [Abstract][Full Text] [Related]
96. The interplay between viruses and TRIM family proteins.
Khan R; Khan A; Ali A; Idrees M
Rev Med Virol; 2019 Mar; 29(2):e2028. PubMed ID: 30609250
[TBL] [Abstract][Full Text] [Related]
97. Innate immunity to RNA virus is regulated by temporal and reversible sumoylation of RIG-I and MDA5.
Hu MM; Liao CY; Yang Q; Xie XQ; Shu HB
J Exp Med; 2017 Apr; 214(4):973-989. PubMed ID: 28250012
[TBL] [Abstract][Full Text] [Related]
98. Structural determinants of TRIM protein function.
Esposito D; Koliopoulos MG; Rittinger K
Biochem Soc Trans; 2017 Feb; 45(1):183-191. PubMed ID: 28202672
[TBL] [Abstract][Full Text] [Related]
99. The ubiquitin E3 ligase TRIM31 promotes aggregation and activation of the signaling adaptor MAVS through Lys63-linked polyubiquitination.
Liu B; Zhang M; Chu H; Zhang H; Wu H; Song G; Wang P; Zhao K; Hou J; Wang X; Zhang L; Gao C
Nat Immunol; 2017 Feb; 18(2):214-224. PubMed ID: 27992402
[TBL] [Abstract][Full Text] [Related]
100. The C-Terminal Tail of TRIM56 Dictates Antiviral Restriction of Influenza A and B Viruses by Impeding Viral RNA Synthesis.
Liu B; Li NL; Shen Y; Bao X; Fabrizio T; Elbahesh H; Webby RJ; Li K
J Virol; 2016 May; 90(9):4369-4382. PubMed ID: 26889027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
